Dr. Abbasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Amgen Center Dr.
Mail Stop 17-1-C
Newbury Park, CA 91320Phone+1 805-447-0238Fax+1 844-447-0238- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Advanced Cardiac Imaging, 2012 - 2014
- University of Illinois College of Medicine at ChicagoFellowship, Cardiovascular Disease, 2009 - 2012
- University of WashingtonResidency, Internal Medicine, 2005 - 2008
- Saint Louis University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2019 - 2025
- RI State Medical License 2014 - 2020
- NY State Medical License 2008 - 2016
- MA State Medical License 2013 - 2014
- IL State Medical License 2009 - 2014
Clinical Trials
- Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity Start of enrollment: 2016 Nov 01
- Reversal of Right Ventricular Steatosis in Pulmonary Hypertension Start of enrollment: 2016 Nov 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsThe Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.Kieran F Docherty, John J V McMurray, Rafael Diaz, G Michael Felker, Marco Metra, Scott D Solomon, Kirkwood F Adams, Michael Böhm, Douglas Marshall Brinkley, Luis E Ec...> ;Journal of Cardiac Failure. 2024 Jan 1
- 31 citationsAssociation Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.Prakriti Gaba, Michelle L O'Donoghue, Jeong-Gun Park, Stephen D Wiviott, Dan Atar, Julia F Kuder, KyungAh Im, Sabina A Murphy, Gaetano M De Ferrari, Zbigniew A Gaciong...> ;Circulation. 2023 Apr 18
- 13 citationsEffects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.Marco Metra, Matteo Pagnesi, Brian L Claggett, Rafael Díaz, G Michael Felker, John J V McMurray, Scott D Solomon, Diana Bonderman, James C Fang, Cândida Fonseca, Eva G...> ;European Heart Journal. 2022 Dec 21
- Join now to see all
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: